What Hormone Replacement Therapy Does

Hormone replacement therapy (HRT) works by introducing hormones—usually estrogen, progesterone, or testosterone—into the body to replace or supplement what your own glands produce. The mechanism is straightforward: hormones are chemical messengers that regulate dozens of processes, from bone density and muscle mass to mood, sleep, and sexual function. When hormone levels drop (as they do during menopause, andropause, or after certain medical treatments), replacing them can restore some of those functions.

The specific effects depend on which hormones you receive, the dose, how long you take them, and your individual biology. A person on estrogen-progesterone therapy will experience different changes than someone on testosterone alone. Research shows measurable shifts in bone density, hot flash frequency, vaginal tissue, muscle composition, and mood within weeks to months—but the magnitude varies widely between individuals.

Key Takeaways

  • HRT replaces hormones your body produces less of, and research documents real changes in bone density, hot flashes, sexual function, and mood within weeks to months.
  • Estrogen-based HRT reduces hot flashes and night sweats in most people, though the effect size differs; bone density typically improves after 12 months of consistent use.
  • Testosterone therapy increases muscle mass and strength in people with low testosterone, with measurable gains appearing after 3 to 6 months.
  • Long-term risks and benefits depend on age at start, duration of use, dose, and individual health history—the research does not support a one-size-fits-all answer.
  • HRT is not a single treatment; the choice between oral, transdermal, or injectable forms, and which hormones to use, shapes both the effects you experience and the risks involved.

How Estrogen and Progesterone Therapy Affects Hot Flashes and Sleep

Hot flashes and night sweats are among the most common reasons people seek HRT. Estrogen directly influences the brain's temperature regulation center, the hypothalamus. When estrogen levels drop during menopause, this center becomes hypersensitive to small changes in core body temperature, triggering sudden vasodilation (blood vessel widening) and sweating. Randomized controlled trials consistently show that estrogen-based HRT reduces hot flash frequency by 75 to 90 percent in most users within 4 to 12 weeks.

The effect on sleep is indirect but measurable. Night sweats disrupt sleep architecture; when sweats decrease, sleep quality often improves. Studies using sleep monitoring show that people on HRT spend more time in deep sleep and wake fewer times per night. However, the magnitude of improvement varies—some people experience near-complete relief, while others see modest gains. Progesterone may add a separate sedative effect, though the evidence is weaker than for estrogen's impact on vasomotor symptoms.

Bone Density Changes and Fracture Risk

Estrogen plays a central role in bone remodeling. Bone is not static; it is constantly broken down and rebuilt. Estrogen slows bone resorption (breakdown) without significantly changing bone formation, so the net effect is preservation of bone mass. When estrogen drops during menopause, bone loss accelerates—women can lose 1 to 3 percent of bone mass per year in the first 5 to 8 years after menopause without treatment.

HRT slows or halts this loss. Randomized trials show that estrogen-based therapy maintains or increases bone mineral density at the hip and spine after 12 months, with continued benefit over 5 to 10 years of use. The clinical question—whether this translates to fewer fractures—is harder to answer because fracture rates are low enough that trials would need thousands of participants over many years. Observational data suggests HRT reduces fracture risk, but the effect size is modest compared to other interventions like weight-bearing exercise or bisphosphonate drugs.

Bone density begins to decline again after HRT stops, so the benefit is not permanent. This matters for long-term planning: HRT can buy time, but it is not a permanent solution to osteoporosis risk.

Muscle Mass and Strength Gains From Testosterone

Testosterone increases protein synthesis in muscle cells and activates satellite cells (which repair and grow muscle tissue). In people with low testosterone—whether from age, medical treatment, or other causes—testosterone therapy produces measurable gains in lean body mass and strength.

Randomized controlled trials in older men with low testosterone show increases in lean mass of 2 to 4 kilograms over 12 months, with corresponding strength gains of 10 to 20 percent in major muscle groups. The effect appears within 3 to 6 months and continues for at least a year. Women receiving testosterone (usually in lower doses) also gain muscle and strength, though fewer long-term trials exist in this population. The gains are real but modest—not comparable to the effects of resistance training, which can produce similar or larger increases.

Testosterone also affects fat distribution, shifting weight toward muscle and away from visceral (abdominal) fat. This metabolic shift may have downstream effects on insulin sensitivity and cardiovascular risk, though the long-term clinical significance remains unclear.

Mood, Cognition, and Sexual Function

Estrogen and testosterone both influence neurotransmitter systems involved in mood and cognition. Estrogen affects serotonin, dopamine, and GABA signaling; testosterone influences dopamine and opioid pathways. Observational studies and some randomized trials show that people starting HRT report improvements in mood, energy, and mental clarity within weeks to months. However, the effect sizes are modest, and placebo effects are large in this domain.

The evidence for cognitive benefit is weaker. Some observational data suggests that estrogen use is associated with lower dementia risk, but randomized trials have not shown that HRT improves memory or processing speed in cognitively normal people. The relationship between HRT and cognition remains an open question, particularly for long-term use.

Sexual function improves in multiple ways: estrogen restores vaginal tissue elasticity and lubrication, reducing pain during intercourse; testosterone increases sexual desire and arousal in both men and women. These effects are well-documented in trials and observational studies, with most people reporting noticeable improvement within 2 to 4 weeks. The magnitude varies widely—some people experience dramatic shifts, others modest ones.

Cardiovascular and Clot Risk: What the Evidence Actually Shows

The relationship between HRT and cardiovascular risk is the most contentious area in the research. The 2002 Women's Health Initiative trial found that estrogen-progestin therapy increased the risk of blood clots, stroke, and heart attack in postmenopausal women over age 50. This led to a sharp decline in HRT use. However, subsequent analysis revealed important nuances: the increased risk was concentrated in women who started HRT more than 10 years after menopause, were older at baseline, or had existing cardiovascular disease. Women who started HRT near menopause (within 5 to 10 years) showed no increased risk of heart attack and possibly lower risk of coronary disease.

Transdermal (patch) estrogen carries lower clot risk than oral estrogen, because it bypasses first-pass liver metabolism and does not increase clotting factors as much. The type of progestin matters too—some formulations carry higher clot risk than others. Testosterone therapy in men shows mixed cardiovascular effects depending on dose, age, and baseline health; some studies suggest benefit, others show increased risk in certain subgroups.

The bottom line: HRT is not uniformly safe or unsafe for the heart and vessels. Risk depends on age at start, duration of use, route of administration, dose, and individual health history. A 52-year-old woman starting transdermal estrogen faces a different risk profile than a 65-year-old starting oral estrogen-progestin.

Cancer Risk and What We Know From Long-Term Data

Estrogen-progestin therapy increases breast cancer risk slightly—roughly 1 to 2 additional cases per 1,000 women per year of use, according to observational studies and the Women's Health Initiative. The risk rises with duration of use and appears to decline after stopping. Estrogen alone (without progestin) does not increase breast cancer risk and may slightly decrease it, but it increases endometrial cancer risk in women with an intact uterus, which is why progestin is added.

Testosterone therapy does not appear to increase prostate cancer risk in men, though the evidence comes from observational studies rather than large randomized trials. The concern remains theoretical rather than demonstrated in practice.

These risks are real but must be weighed against benefits and individual baseline risk. A woman with a strong family history of breast cancer faces a different calculation than one with no family history. Age, smoking status, alcohol use, and obesity all modify baseline cancer risk independently of HRT.

Frequently Asked Questions

How long does it take to feel effects from HRT?

Hot flashes and night sweats often improve within 2 to 4 weeks. Mood and energy changes appear within 4 to 8 weeks. Bone density changes take 12 months to measure. Muscle gains from testosterone appear after 3 to 6 months. Individual variation is large—some people notice shifts within days, others take months.

Is HRT safe to use long-term?

Long-term safety depends on age at start, which hormones you use, the dose, and your health history. Starting near menopause with the lowest effective dose for the shortest duration needed appears safer than starting years later at higher doses. No research supports indefinite use without periodic reassessment, but some people use HRT for 10+ years without serious complications.

Can I use HRT if I have a history of blood clots?

Oral estrogen increases clot risk and is generally avoided. Transdermal estrogen carries lower risk. Testosterone therapy does not significantly increase clot risk. Your doctor needs to know your specific history to advise whether HRT is appropriate for you.

Does HRT work the same way for everyone?

No. Individual response varies based on genetics, age, baseline hormone levels, body composition, and other medications. Some people experience dramatic relief from symptoms; others see modest changes. Dose and formulation often need adjustment to find what works for your body.

What happens when I stop taking HRT?

Symptoms like hot flashes often return within weeks to months. Bone density begins to decline again. Muscle gains fade without continued resistance training. Mood and sexual function may shift back toward baseline. The speed of change varies individually.